The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Coherus BioSciences Inc

Nasdaq: CHRS
Last

(U.S.) $27.90

Today's change+0.35 +1.27%
Updated December 2 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Coherus BioSciences Inc

Nasdaq: CHRS
Last

(U.S.) $27.90

Today's change+0.35 +1.27%
Updated December 2 4:00 PM -5GMT. Delayed by at least 15 minutes.

Coherus BioSciences Inc up (U.S.)$0.35

Coherus BioSciences Inc closed up Friday by (U.S.)$0.35 or 1.27% to (U.S.)$27.90. Shares have lost 0.53% over the last five days, but have gained 21.52% over the last year to date. This security has underperformed the S&P 500 by 11.88% during the last year.

Key company metrics

  • Open(U.S.) $27.60
  • Previous close(U.S.) $27.55
  • High(U.S.) $28.10
  • Low(U.S.) $27.15
  • Bid / Ask(U.S.) $23.30 / (U.S.) $30.00
  • YTD % change+21.52%
  • Volume157,420
  • Average volume (10-day)279,046
  • Average volume (1-month)450,502
  • Average volume (3-month)405,488
  • 52-week range(U.S.) $12.04 to (U.S.) $31.98
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.11
Updated December 2 4:00 PM -5GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue163141210
Total other revenue--------
Total revenue163141210
Gross profit--------
Total cost of revenue--------
Total operating expense78777762
Selling / general / administrative14111111
Research & development65666551
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income85-63-64-52
Interest income (expense), net non-operating-2-2-10
Gain (loss) on sale of assets--------
Other--------
Income before tax84-70-66-53
Income after tax84-70-66-53
Income tax, total----0--
Net income84-70-65-52
Total adjustments to net income--------
Net income before extra. items84-70-65-52
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items84-70-65-52
Inc. avail. to common incl. extra. items84-70-65-52
Diluted net income84-70-65-52
Dilution adjustment0------
Diluted weighted average shares52413939
Diluted EPS excluding extraordinary itemsvalue per share1.63-1.72-1.67-1.34
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.63-1.72-1.67-1.34